Lidoryx 5% Gel
Product Images NDC 85477-731

2 FDA label images from Oncora Pharma, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lidoryx 5% (NDC 85477-731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oncora Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lidoryx 1)

Chemical Structure (Lidoryx 1)
Chemical structure of Lidocaine hydrochloride, showing the molecular formula C14H23ClN2O and molecular weight 270.8. The structure includes a benzene ring with methyl groups, an amide group, and a hydrochloride moiety.*
FDA Label Image

Pdp (Lidoryx 2)

Pdp (Lidoryx 2)
Label for Lidoryx 5% gel, a topical human prescription drug containing Lidocaine HCl 50 mg/g. The label shows the brand name LidexaGel and indicates it is a topical anesthetic and anti-inflammatory. The product is packaged in a 3 oz (85 g) tube, labeled by Oncora Pharma, LLC, with directions, warnings, storage instructions, and a barcode visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.